Healthcare provider profile · identity verified

Terri Brooks, CNS

Certified Clinical Nurse Specialist · CLEVELAND, OH · NPI 1528167624

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	333	105
Atorvastatin Calcium	Atorvastatin Calcium	259	94
Lisinopril	Lisinopril	252	82
Levothyroxine Sodium	Levothyroxine Sodium	215	71
Gabapentin	Gabapentin	196	53
Omeprazole	Omeprazole	193	69
Losartan Potassium	Losartan Potassium	150	48
Rosuvastatin Calcium	Rosuvastatin Calcium	148	49
Pantoprazole Sodium	Pantoprazole Sodium	135	47
Metoprolol Succinate	Metoprolol Succinate	111	40
Trazodone Hcl	Trazodone Hcl	111	37
Albuterol Sulfate Hfa	Albuterol Sulfate	109	71
Metformin Hcl Er	Metformin Hcl	106	36
Sertraline Hcl	Sertraline Hcl	101	29
Furosemide	Furosemide	98	37
Meloxicam	Meloxicam	95	50
Hydrochlorothiazide	Hydrochlorothiazide	91	34
Metformin Hcl	Metformin Hcl	91	24
Simvastatin	Simvastatin	87	29
Prednisone	Prednisone	82	71
Pravastatin Sodium	Pravastatin Sodium	79	23
Escitalopram Oxalate	Escitalopram Oxalate	76	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	35
Potassium Chloride	Potassium Chloride	72	30
Famotidine	Famotidine	70	23
Metoprolol Tartrate	Metoprolol Tartrate	67	20
Atenolol	Atenolol	64	25
Montelukast Sodium	Montelukast Sodium	64	19
Venlafaxine Hcl Er	Venlafaxine Hcl	63	17
Duloxetine Hcl	Duloxetine Hcl	61	22
Spironolactone	Spironolactone	61	17
Warfarin Sodium	Warfarin Sodium	61	20
Fluticasone Propionate	Fluticasone Propionate	59	33
Paroxetine Hcl	Paroxetine Hcl	58	15
Bupropion Xl	Bupropion Hcl	54	suppressed
Glimepiride	Glimepiride	54	13
Carvedilol	Carvedilol	53	suppressed
Alendronate Sodium	Alendronate Sodium	51	14
Oxybutynin Chloride Er	Oxybutynin Chloride	49	13
Eliquis	Apixaban	47	16
Allopurinol	Allopurinol	43	17
Celecoxib	Celecoxib	43	15
Amitriptyline Hcl	Amitriptyline Hcl	41	14
Tizanidine Hcl	Tizanidine Hcl	41	25
Pregabalin	Pregabalin	38	11
Buspirone Hcl	Buspirone Hcl	37	16
Zolpidem Tartrate	Zolpidem Tartrate	37	22
Mupirocin	Mupirocin	36	25
Citalopram Hbr	Citalopram Hydrobromide	35	14
Synthroid	Levothyroxine Sodium	35	14
Tamsulosin Hcl	Tamsulosin Hcl	35	16
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	20
Naproxen	Naproxen	31	12
Triamcinolone Acetonide	Triamcinolone Acetonide	31	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Doxycycline Hyclate	Doxycycline Hyclate	30	24
Ozempic	Semaglutide	29	suppressed
Topiramate	Topiramate	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Nabumetone	Nabumetone	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	25
Ondansetron Odt	Ondansetron	26	20
Azithromycin	Azithromycin	25	23
Lorazepam	Lorazepam	25	15
Sucralfate	Sucralfate	24	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Ketoconazole	Ketoconazole	20	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	12
Cephalexin	Cephalexin	18	13
Estradiol	Estradiol	18	11
Glipizide Er	Glipizide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Amoxicillin	Amoxicillin	17	13
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	12
Valsartan	Valsartan	17	suppressed
Alprazolam	Alprazolam	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluconazole	Fluconazole	14	12
Jardiance	Empagliflozin	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Cholestyramine Light	Cholestyramine	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Prevacid	Lansoprazole	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error